Personal tools
Search Web Site

Bridging Anticoagulation in Patients who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery.

The goal of the BRIDGE study is to establish an evidence-based standard-of-care for the large number of patients who require temporary interruption of warfarin because of an elective procedure or surgery.


Enrollment Reports


         Enrollment Report for January 2, 2015


New webinar available  

Watch the webinar: "A discussion of recent studies and new oral anticoagulation options."
Presenters: James Douketis, MD, FRCPC, FACP and Thomas Ortel, MD, PhD

View the flyer for more details, and view these related slides on BRIDGE relevance


Participate in BRIDGE

Are you taking Coumadin (warfarin) for atrial fibrillation or atrial flutter? Are you planning to have a surgical procedure? You may be eligible to participate in the BRIDGE study.

Learn more


Now Recruiting Sites

The Duke Clinical Research Institute would like to invite your site to participate in the BRIDGE study.

Become a site
Who we are

The BRIDGE Study is coordinated by the Duke Clinical Research Institute and sponsored by the National Heart, Lung, and Blood Institute. 

Clinical and Data Coordinating Center